Clinical Trials
4 trialsNCT07045935 2025-09-23
ProBOLIC
University Hospital, Basel, Switzerland
Phase 4 Recruiting
NCT07034859 2025-06-24
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital
Phase 4 Enrolling by invitation
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed